FMR LLC 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-08-06 11:51 am Purchase | 2025-06-30 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 15,083,498 15.000% | 5,041,406![]() (+50.20%) | Filing |
2025-04-02 11:02 am Purchase | 2025-03-31 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 10,042,092 10.100% | 4,602,759![]() (+84.62%) | Filing |
2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 5,439,333 6.600% | -961,813![]() (-15.03%) | Filing |
2024-11-12 09:50 am Sale | 2024-11-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,401,146 7.766% | -2,552,654![]() (-28.51%) | Filing |
2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 8,953,800 10.985% | 1,184,784![]() (+15.25%) | Filing |
2023-02-09 08:14 am Purchase | 2023-02-09 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 7,769,016 11.024% | 1,779,318![]() (+29.71%) | Filing |
2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 5,989,698 8.790% | -828,724![]() (-12.15%) | Filing |
2022-01-24 08:40 am Sale | 2022-01-21 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,818,422 10.007% | -510,164![]() (-6.96%) | Filing |
2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 7,328,586 12.642% | 356,674![]() (+5.12%) | Filing |